Pfizer Beats Forecasts as Vaccine Trial Enters Final Stage – The Wall Street Journal

Pfizer Inc. reported development in its biopharma division in the newest quarter, however general sales fell in the middle of increased competition in its generic-drug service.
The New York City-based pharmaceutical co. [+149 chars]